In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule
- 1 June 1992
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 73 (3) , 134-136
- https://doi.org/10.1016/0962-8479(92)90145-a
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1989
- In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisTubercle, 1987
- In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisTubercle, 1987
- Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric techniqueJournal of Antimicrobial Chemotherapy, 1982
- Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 1981
- MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesAntimicrobial Agents and Chemotherapy, 1980